TEVA PHARMACEUTICAL INDUSTRIES LIMITED Property, Plant and Equipment, Other, Gross
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Property, Plant and Equipment, Other, Gross of $2.51 billion as of 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentOther · last filed 2026-02-03
- 2025-12-31: Property, Plant and Equipment, Other, Gross $2.51B.
- 2024-12-31: Property, Plant and Equipment, Other, Gross $2.39B.
- 2023-12-31: Property, Plant and Equipment, Other, Gross $2.42B.
- 2022-12-31: Property, Plant and Equipment, Other, Gross $2.32B.
| Period end | Property, Plant and Equipment, Other, Gross | Property, Plant and Equipment, Other, Gross as first filed |
|---|---|---|
| 2025-12-31 | $2.51B 10-K · filed 2026-02-03 | |
| 2024-12-31 | $2.39B 10-K · filed 2026-02-03 | |
| 2023-12-31 | $2.42B 10-K · filed 2025-02-05 | |
| 2022-12-31 | $2.32B 10-K · filed 2024-02-12 | |
| 2021-12-31 | $2.26B 10-K · filed 2023-02-10 | |
| 2020-12-31 | $2.20B 10-K · filed 2022-02-09 | |
| 2019-12-31 | $2.13B 10-K · filed 2021-02-10 | |
| 2019-09-30 | $2.12B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.13B 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $2.11B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $2.09B 10-K · filed 2020-02-21 | $2.10B 10-K · filed 2019-02-19 |
| 2018-09-30 | $2.12B 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $2.08B 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $2.06B 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $2.02B 10-K · filed 2019-02-19 | |
| 2017-09-30 | $1.98B 6-K · filed 2017-11-02 | |
| 2017-06-30 | $1.93B 6-K · filed 2017-08-03 | |
| 2017-03-31 | $1.85B 6-K · filed 2017-05-11 | |
| 2016-12-31 | $1.77B 10-K · filed 2018-02-12 | |
| 2016-09-30 | $1.74B 6-K · filed 2016-11-15 | |
| 2015-12-31 | $1.49B 20-F · filed 2017-02-15 | |
| 2014-12-31 | $1.39B 20-F · filed 2016-02-11 | |
| 2013-12-31 | $1.31B 20-F · filed 2015-02-09 | |
| 2012-12-31 | $1.20B 20-F · filed 2014-02-10 | |
| 2011-12-31 | $1.06B 20-F · filed 2013-02-12 | |
| 2010-12-31 | $858.00M 20-F · filed 2012-02-17 | |
| 2009-12-31 | $721.00M 20-F · filed 2011-02-15 |